(195) - CD38-Antibody Daratumumab in Allosensitized Recipients for Heart Transplantation: Outcomes and 3-Years of Single-Centre Experience. - Atteneder, C.; Moayedifar, R.; Koren, D.; Fischer, G.; Nackenhorst, M.; Uyanik-Uenal, K.; Goekler, J.; Boehmig, G.; Aliabadi-Zuckermann, A.; Zuckermann, A. (Journal of Heart & Lung Transplantation, 2024)